RMTIROCKWELL MEDICAL, INC.

Nasdaq rockwellmed.com


$ 1.59 $ 0.04 (2.58 %)    

Thursday, 02-May-2024 14:37:29 EDT
QQQ $ 426.81 $ 1.56 (0.37 %)
DIA $ 382.25 $ 0.64 (0.17 %)
SPY $ 504.94 $ 0.54 (0.11 %)
TLT $ 88.94 $ 0.72 (0.82 %)
GLD $ 213.49 $ 1.03 (0.48 %)
$ 1.54
$ 1.55
$ 0.00 x 0
$ 1.62 x 200
$ 1.54 - $ 1.59
$ 1.16 - $ 6.24
42,502
na
35.92M
$ 1.48
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-14-2023 06-30-2023 10-Q
4 05-15-2023 03-31-2023 10-Q
5 03-30-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-16-2022 03-31-2022 10-Q
9 04-08-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-16-2021 06-30-2021 10-Q
12 05-17-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-09-2020 09-30-2020 10-Q
15 08-10-2020 06-30-2020 10-Q
16 05-11-2020 03-31-2020 10-Q
17 03-17-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-09-2019 06-30-2019 10-Q
20 05-10-2019 03-31-2019 10-Q
21 03-18-2019 12-31-2018 10-K
22 11-09-2018 09-30-2018 10-Q
23 08-14-2018 06-30-2018 10-Q
24 05-10-2018 03-31-2018 10-Q
25 03-15-2018 12-31-2017 10-K
26 11-08-2017 09-30-2017 10-Q
27 08-09-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 03-15-2017 12-31-2016 10-K
30 11-07-2016 09-30-2016 10-Q
31 08-09-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-04-2015 06-30-2015 10-Q
36 05-07-2015 03-31-2015 10-Q
37 03-03-2015 12-31-2014 10-K
38 11-10-2014 09-30-2014 10-Q
39 07-31-2014 06-30-2014 10-Q
40 05-12-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rockwell-medical-enters-new-and-expanded-distribution-agreement-with-bionuclear-and-atlantic-medical-international

In the aggregate, these agreements are expected to generate approximately $1 million in annual revenues for the Company. The am...

 hc-wainwright--co-maintains-buy-on-rockwell-medical-lowers-price-target-to-9

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Rockwell Medical (NASDAQ:RMTI) with a Buy and lowers the price ...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

 rockwell-medical-q4-adjusted-eps-002-may-not-be-comparable-to-007-estimate-sales-2210m-miss-2263m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0....

 rockwell-medical-amends-loan-and-security-agreement-with-innovatus-narrows-full-year-2023-guidance-to-828m-838m-est-8415m

Rockwell Medical projects net sales in the fourth quarter of 2023 to be between $21.3 million and $22.3 million, a 10% to 16% i...

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-11-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $11 pr...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

 rockwell-medical-q3-eps-007-beats-010-estimate-sales-2377m-beat-2285m-estimate

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0....

 maxim-group-initiates-coverage-on-rockwell-medical-with-buy-rating-announces-price-target-of-5

Maxim Group analyst Anthony Vendetti initiates coverage on Rockwell Medical (NASDAQ:RMTI) with a Buy rating and announces Pr...

 hc-wainwright--co-reiterates-buy-on-rockwell-medical-maintains-11-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Rockwell Medical (NASDAQ:RMTI) with a Buy and maintains $11 pr...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION